HEADER TRANSCRIPTION 31-AUG-14 4UYH TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-((2R,4S)-2-METHYL-4- TITLE 2 (PHENYLAMINO)-6-(4-(PIPERIDIN-1-YLMETHYL)PHENYL)-3,4-DIHYDROQUINOLIN- TITLE 3 1(2H)-YL)ETHANONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN, RESIDUES 67-200; COMPND 5 SYNONYM: O27.1.1, REALLY INTERESTING NEW GENE 3 PROTEIN, HUMAN BRD2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION, HISTONE, EPIGENETIC READER, BET, BRD2, BROMODOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR C.CHUNG,P.BAMBOROUGH,R.GOSMINI REVDAT 3 15-MAY-19 4UYH 1 REMARK REVDAT 2 22-OCT-14 4UYH 1 JRNL REVDAT 1 08-OCT-14 4UYH 0 JRNL AUTH R.GOSMINI,V.L.NGUYEN,J.TOUM,C.SIMON,J.M.BRUSQ,G.KRYSA, JRNL AUTH 2 O.MIRGUET,A.M.RIOU-EYMARD,E.V.BOURSIER,L.TROTTET, JRNL AUTH 3 P.BAMBOROUGH,H.CLARK,C.W.CHUNG,L.CUTLER,E.H.DEMONT,R.KAUR, JRNL AUTH 4 A.J.LEWIS,M.B.SCHILLING,P.E.SODEN,S.TAYLOR,A.L.WALKER, JRNL AUTH 5 M.D.WALKER,R.K.PRINJHA,E.NICODEME JRNL TITL THE DISCOVERY OF I-BET726 (GSK1324726A), A POTENT JRNL TITL 2 TETRAHYDROQUINOLINE APOA1 UP-REGULATOR AND SELECTIVE BET JRNL TITL 3 BROMODOMAIN INHIBITOR. JRNL REF J.MED.CHEM. V. 57 8111 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25249180 JRNL DOI 10.1021/JM5010539 REMARK 2 REMARK 2 RESOLUTION. 1.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 39661 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2107 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.73 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.78 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1604 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 52.71 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 90 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2677 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 77 REMARK 3 SOLVENT ATOMS : 396 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.05000 REMARK 3 B22 (A**2) : -0.46000 REMARK 3 B33 (A**2) : -0.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.94000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.108 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.105 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.072 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.355 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2968 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2028 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4039 ; 0.982 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4964 ; 0.804 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 340 ; 4.162 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 131 ;37.235 ;24.733 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 525 ;11.113 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;21.108 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 420 ; 0.053 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3238 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 618 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 75 A 183 REMARK 3 ORIGIN FOR THE GROUP (A): 16.5321 6.9672 1.3900 REMARK 3 T TENSOR REMARK 3 T11: 0.0243 T22: 0.0305 REMARK 3 T33: 0.0666 T12: 0.0068 REMARK 3 T13: 0.0341 T23: -0.0062 REMARK 3 L TENSOR REMARK 3 L11: 0.5224 L22: 0.5309 REMARK 3 L33: 0.7828 L12: -0.4025 REMARK 3 L13: 0.0167 L23: -0.0158 REMARK 3 S TENSOR REMARK 3 S11: -0.0397 S12: -0.0033 S13: -0.0507 REMARK 3 S21: 0.0499 S22: -0.0203 S23: 0.0785 REMARK 3 S31: -0.0095 S32: -0.0551 S33: 0.0600 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 76 B 182 REMARK 3 ORIGIN FOR THE GROUP (A): 35.2894 8.6350 10.3559 REMARK 3 T TENSOR REMARK 3 T11: 0.0593 T22: 0.0029 REMARK 3 T33: 0.0574 T12: 0.0006 REMARK 3 T13: -0.0226 T23: 0.0034 REMARK 3 L TENSOR REMARK 3 L11: 0.1797 L22: 1.0121 REMARK 3 L33: 0.8523 L12: -0.1927 REMARK 3 L13: 0.0224 L23: 0.0642 REMARK 3 S TENSOR REMARK 3 S11: 0.0307 S12: 0.0069 S13: -0.0287 REMARK 3 S21: 0.1156 S22: 0.0095 S23: -0.0903 REMARK 3 S31: -0.0288 S32: 0.0116 S33: -0.0402 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 77 C 181 REMARK 3 ORIGIN FOR THE GROUP (A): -1.6555 18.7152 23.4569 REMARK 3 T TENSOR REMARK 3 T11: 0.0199 T22: 0.1128 REMARK 3 T33: 0.0150 T12: -0.0180 REMARK 3 T13: 0.0078 T23: 0.0072 REMARK 3 L TENSOR REMARK 3 L11: 0.2158 L22: 1.3208 REMARK 3 L33: 2.2117 L12: 0.0085 REMARK 3 L13: 0.6791 L23: -0.2844 REMARK 3 S TENSOR REMARK 3 S11: -0.0387 S12: 0.0485 S13: -0.0499 REMARK 3 S21: -0.1289 S22: 0.2028 S23: 0.0260 REMARK 3 S31: -0.0846 S32: 0.1122 S33: -0.1642 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4UYH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1290061647. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5417 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU A200 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41770 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.730 REMARK 200 RESOLUTION RANGE LOW (A) : 45.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.0, 26% PEG3350, 0.2M REMARK 280 (NH4)2SO4 20C, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.36100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.88050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.36100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.88050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 SER A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 SER A 56 REMARK 465 SER A 57 REMARK 465 GLY A 58 REMARK 465 LEU A 59 REMARK 465 VAL A 60 REMARK 465 PRO A 61 REMARK 465 ARG A 62 REMARK 465 GLY A 63 REMARK 465 SER A 64 REMARK 465 HIS A 65 REMARK 465 MET A 66 REMARK 465 SER A 67 REMARK 465 ASN A 68 REMARK 465 PRO A 69 REMARK 465 LYS A 70 REMARK 465 LYS A 71 REMARK 465 PRO A 72 REMARK 465 GLY A 73 REMARK 465 ARG A 74 REMARK 465 GLU A 184 REMARK 465 GLN A 185 REMARK 465 GLU A 186 REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 SER A 195 REMARK 465 HIS A 196 REMARK 465 LYS A 197 REMARK 465 LYS A 198 REMARK 465 GLY A 199 REMARK 465 ALA A 200 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 SER B 49 REMARK 465 HIS B 50 REMARK 465 HIS B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 SER B 56 REMARK 465 SER B 57 REMARK 465 GLY B 58 REMARK 465 LEU B 59 REMARK 465 VAL B 60 REMARK 465 PRO B 61 REMARK 465 ARG B 62 REMARK 465 GLY B 63 REMARK 465 SER B 64 REMARK 465 HIS B 65 REMARK 465 MET B 66 REMARK 465 SER B 67 REMARK 465 ASN B 68 REMARK 465 PRO B 69 REMARK 465 LYS B 70 REMARK 465 LYS B 71 REMARK 465 PRO B 72 REMARK 465 GLY B 73 REMARK 465 ARG B 74 REMARK 465 VAL B 75 REMARK 465 GLU B 183 REMARK 465 GLU B 184 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 SER B 195 REMARK 465 HIS B 196 REMARK 465 LYS B 197 REMARK 465 LYS B 198 REMARK 465 GLY B 199 REMARK 465 ALA B 200 REMARK 465 GLY C 47 REMARK 465 SER C 48 REMARK 465 SER C 49 REMARK 465 HIS C 50 REMARK 465 HIS C 51 REMARK 465 HIS C 52 REMARK 465 HIS C 53 REMARK 465 HIS C 54 REMARK 465 HIS C 55 REMARK 465 SER C 56 REMARK 465 SER C 57 REMARK 465 GLY C 58 REMARK 465 LEU C 59 REMARK 465 VAL C 60 REMARK 465 PRO C 61 REMARK 465 ARG C 62 REMARK 465 GLY C 63 REMARK 465 SER C 64 REMARK 465 HIS C 65 REMARK 465 MET C 66 REMARK 465 SER C 67 REMARK 465 ASN C 68 REMARK 465 PRO C 69 REMARK 465 LYS C 70 REMARK 465 LYS C 71 REMARK 465 PRO C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 THR C 76 REMARK 465 GLN C 182 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 465 SER C 195 REMARK 465 HIS C 196 REMARK 465 LYS C 197 REMARK 465 LYS C 198 REMARK 465 GLY C 199 REMARK 465 ALA C 200 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 GLN B 182 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 123 SD MET A 123 CE 0.354 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 123 CG - SD - CE ANGL. DEV. = -10.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU C 110 72.18 -119.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A3093 DISTANCE = 7.85 ANGSTROMS REMARK 525 HOH B2033 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH B2042 DISTANCE = 6.59 ANGSTROMS REMARK 525 HOH B2044 DISTANCE = 6.47 ANGSTROMS REMARK 525 HOH B3094 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH B3095 DISTANCE = 8.22 ANGSTROMS REMARK 525 HOH C2096 DISTANCE = 6.08 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS C 1182 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9S3 A 1184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9S3 B 1183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1184 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UYD RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3- DIMETHYL-2-OXO-2,3- REMARK 900 DIHYDRO-1H-1,3-BENZODIAZOLE-5- CARBOXAMIDE REMARK 900 RELATED ID: 4UYE RELATED DB: PDB REMARK 900 BROMODOMAIN OF HUMAN BRPF1 WITH N-1,3-DIMETHYL-2- OXO-6-(PIPERIDIN- REMARK 900 1-YL)-2,3-DIHYDRO-1H-1,3- BENZODIAZOL-5-YL-2-METHOXYBENZAMIDE REMARK 900 RELATED ID: 4UYF RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH I-BET726 ( GSK1324726A) REMARK 900 RELATED ID: 4UYG RELATED DB: PDB REMARK 900 C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH I-BET726 ( GSK1324726A) DBREF 4UYH A 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4UYH B 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4UYH C 67 200 UNP P25440 BRD2_HUMAN 67 200 SEQADV 4UYH GLY A 47 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER A 48 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER A 49 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 50 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 51 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 52 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 53 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 54 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 55 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER A 56 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER A 57 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY A 58 UNP P25440 EXPRESSION TAG SEQADV 4UYH LEU A 59 UNP P25440 EXPRESSION TAG SEQADV 4UYH VAL A 60 UNP P25440 EXPRESSION TAG SEQADV 4UYH PRO A 61 UNP P25440 EXPRESSION TAG SEQADV 4UYH ARG A 62 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY A 63 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER A 64 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS A 65 UNP P25440 EXPRESSION TAG SEQADV 4UYH MET A 66 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY B 47 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER B 48 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER B 49 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 50 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 51 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 52 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 53 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 54 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 55 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER B 56 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER B 57 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY B 58 UNP P25440 EXPRESSION TAG SEQADV 4UYH LEU B 59 UNP P25440 EXPRESSION TAG SEQADV 4UYH VAL B 60 UNP P25440 EXPRESSION TAG SEQADV 4UYH PRO B 61 UNP P25440 EXPRESSION TAG SEQADV 4UYH ARG B 62 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY B 63 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER B 64 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS B 65 UNP P25440 EXPRESSION TAG SEQADV 4UYH MET B 66 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY C 47 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER C 48 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER C 49 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 50 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 51 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 52 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 53 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 54 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 55 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER C 56 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER C 57 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY C 58 UNP P25440 EXPRESSION TAG SEQADV 4UYH LEU C 59 UNP P25440 EXPRESSION TAG SEQADV 4UYH VAL C 60 UNP P25440 EXPRESSION TAG SEQADV 4UYH PRO C 61 UNP P25440 EXPRESSION TAG SEQADV 4UYH ARG C 62 UNP P25440 EXPRESSION TAG SEQADV 4UYH GLY C 63 UNP P25440 EXPRESSION TAG SEQADV 4UYH SER C 64 UNP P25440 EXPRESSION TAG SEQADV 4UYH HIS C 65 UNP P25440 EXPRESSION TAG SEQADV 4UYH MET C 66 UNP P25440 EXPRESSION TAG SEQRES 1 A 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 A 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 A 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 A 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 A 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 A 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 A 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 A 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 A 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 A 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 A 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 B 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 B 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 B 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 B 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 B 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 B 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 B 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 B 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 B 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 B 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 B 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 B 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 C 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 C 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 C 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 C 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 C 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 C 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 C 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 C 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 C 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 C 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 C 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 C 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA HET 9S3 A1184 34 HET 9S3 B1183 68 HET SO4 B1184 5 HET DMS C1182 4 HETNAM 9S3 1-[(2S,4R)-2-METHYL-4-(PHENYLAMINO)-6-[4-(PIPERIDIN-1- HETNAM 2 9S3 YLMETHYL)PHENYL]-3,4-DIHYDROQUINOLIN-1(2H)-YL]ETHANONE HETNAM SO4 SULFATE ION HETNAM DMS DIMETHYL SULFOXIDE FORMUL 4 9S3 2(C30 H35 N3 O) FORMUL 6 SO4 O4 S 2- FORMUL 7 DMS C2 H6 O S FORMUL 8 HOH *396(H2 O) HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 LYS A 92 1 8 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 104 GLY A 109 1 6 HELIX 5 5 ASP A 112 ILE A 117 1 6 HELIX 6 6 ASP A 122 ASN A 132 1 11 HELIX 7 7 ALA A 137 ASN A 156 1 20 HELIX 8 8 ASP A 160 ALA A 178 1 19 HELIX 9 9 THR B 76 VAL B 85 1 10 HELIX 10 10 VAL B 85 HIS B 93 1 9 HELIX 11 11 ALA B 96 ARG B 100 5 5 HELIX 12 12 ASP B 112 ILE B 117 1 6 HELIX 13 13 ASP B 122 ASN B 132 1 11 HELIX 14 14 ALA B 137 ASN B 156 1 20 HELIX 15 15 ASP B 160 SER B 179 1 20 HELIX 16 16 ASN C 77 VAL C 85 1 9 HELIX 17 17 VAL C 85 LYS C 92 1 8 HELIX 18 18 ALA C 96 ARG C 100 5 5 HELIX 19 19 ASP C 112 ILE C 117 1 6 HELIX 20 20 ASP C 122 ASN C 132 1 11 HELIX 21 21 ALA C 137 ASN C 156 1 20 HELIX 22 22 ASP C 160 SER C 179 1 20 SITE 1 AC1 4 VAL C 103 ASN C 156 ILE C 162 HOH C2038 SITE 1 AC2 9 TRP A 97 PRO A 98 LYS A 107 LEU A 108 SITE 2 AC2 9 LEU A 110 ASN A 156 ILE A 162 HOH A2071 SITE 3 AC2 9 GLN B 94 SITE 1 AC3 8 GLN A 94 PRO B 98 LYS B 107 LEU B 108 SITE 2 AC3 8 LEU B 110 ASN B 156 ILE B 162 HOH B2050 SITE 1 AC4 8 ARG B 100 HOH B2016 HOH B2018 HOH B2126 SITE 2 AC4 8 ARG C 128 ASN C 132 TYR C 134 HOH C2057 CRYST1 114.722 55.761 67.896 90.00 94.40 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008717 0.000000 0.000671 0.00000 SCALE2 0.000000 0.017934 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014772 0.00000